Using Virtual Reality to Teach Mindfulness to People With Migraine
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorBrigham and Women's Hospital
About this trial
The aim of this clinical trial is to learn if people with migraine can learn a type of biobehavioral therapy called Acceptance and Commitment Therapy (ACT) by using a virtual reality headset. Researchers are studying if this type of mindfulness therapy helps to decrease migraine-related disability. Participants will be randomized to treatment as usual or active virtual reality groups for four weeks. Everyone will keep symptom diaries, complete surveys, attend two clinic visits, and have two blood draws.
Eligibility criteria
Qualifiers
Adults aged 18-80
Diagnosed with episodic migraine and experience 4-10 migraine days/month
On a stable dose of CGRP mAb for three months prior
Satisfy 4 week run-in of 4-10 headaches/month
Disqualifiers
Medication overuse (>10 days/month)
Vertigo/vestibular dysfunction
Active psychiatric or neurological comorbidities
Pregnancy, breastfeeding or planning pregnancy within study timeframe
Trial design
Treatments tested in this trial
- ACT therapy delivered by REACT NeuroVR headset
Treatment groups
160 Participants
are divided into 2 treatment groupsLocations
3Brigham and Womens Hospital02155, BostonMassachusetts, United States
Brigham and Women's Health Care Center02467, Chestnut HillMassachusetts, United States
Brigham and Women's Hospital02467, Chestnut HillMassachusetts, United States
Sponsors and collaborators
Brigham and Women's Hospital
Lead sponsor
Source ClinicalTrials.gov